EGFRvIII peptide

CAT: 0013-GTR19062929-01Size: 50 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0013-GTR19062929-01Size:50 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

This peptide, derived from the EGFRvIII mutant protein and presented by MHC I, can be used in glioblastoma research. When administered alone or conjugated with Flagellin B, it induces apoptosis and stimulates targeted immune responses in both in vitro and in vivo experimental models.

Field of Research

Cell Biology

Molecular Weight

1079.20

Storage Conditions

-20°C

Notes

For research use only.

Related Products

Catalog	Name
GTR18997896	EGFRvIII Antibody Blocking Peptide
GTR18317674-01	EGFRVIII Antibody
GTR18406411-01	EGFRVIII Antibody
GTR18685841-01	EGFRvIII Monoclonal Antibody
GTR18320643	Anti-EGFRvIII [806]
GTR18047759-01	EGFRvIII monoclonal antibody
GTR18320642	Anti-EGFRvIII [806]
GTR18103299-01	EGFRvIII Rabbit Polyclonal Antibody
GTR18777365-01	Resaerch Grade EGFRvIII Antibody
GTR18229318	EGFRvIII Antibody HRP Conjugated

Alternative Products

Catalog	Name
TP2703-01	EGFRvIII peptide
TP1589-01	EGFRvIII peptide (PEPvIII)
M30288	EGFRvIII peptide PEPvIII
T83852-01	EGFRvIII Peptide TFA
MBS5789305	EGFRvIII peptide PEPvIII acetate
HY-P1828A-01	EGFRvIII peptide (PEPvIII) (TFA)
052478	EGFRvIII Mutation
052479	EGFRvIII, Mutant
E55A15771	Human EGFRvIII Antibody
MBS489079-01	Anti-EGFRvIII [806]

EGFRvIII peptide

Related Products

Alternative Products

Popular Products